Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACADIA: As-needed AIRSUPRA versus albuterol in adolescents with asthma
CTR20243237Phase 3Active
- Sponsor
- AstraZeneca
- Start
- Apr 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salbutamol + budesonide, salbutamol in asthma, sponsored by AstraZeneca. Started Apr 2025; status: active.
02
Drugs
salbutamol + budesonidesalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20243237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243237.